Health Services
Events
-
-
Doxycycline vs. Benzathine Penicillin G for Treatment of Syphilis: A Retrospective Analysis from a Large Sexual Health Organization
Limited evidence suggests that doxycycline may be comparable to penicillin for the treatment of syphilis, but perhaps less so for latent stages. A total of 655 individuals were included, 539 who were treated with benzathine PCN G (BPG) and 116 treated with doxycycline. For our primary analysis, we included all RPR titers up to 24 months after treatment for all stages of syphilis treated from April 2022 through September 2023.
-
Borderless Prevention
This comparative analysis explores HIV prevention, PrEP (pre-exposure prophylaxis), and health equity across two critical border regions: San Diego–Tijuana and Brownsville–Matamoros. These binational corridors reflect unique public health dynamics shaped by migration, resource allocation, stigma, and cross-border collaboration. While San Diego and Brownsville benefit from robust U.S. public health infrastructure, their Mexican counterparts often face limitations in consistent access to HIV testing, PrEP availability, and stigma-free services.
-
Findings From a Formative Evaluation of Hepatitis C Virus (HCV) Care and Treatment Co-Located in Non-Traditional Service Settings for People Who Use Drugs in New York State
Understanding that the complexity and segmentation of the healthcare system can pose unique challenges to providing medical care in non-traditional settings in the United States, a formative evaluation was conducted to assess the feasibility, acceptability, and effectiveness, and whether enrolled clients completed the care cascade measured by four performance indicators: linkage to care, treatment initiation, treatment completion, and achievement of SVR-12.
-
Iowa ReLink: Lessons Learned and Informing Future Directions for Ending HCV with a Syndemic Response
This session will review the project design and provide an overview of preliminary project outcomes, specifically focusing on the unique role State Health Agencies are equipped to fulfill when seeking to generate registries, verify eligibility, and engage individuals. Finally, the session will discuss how these activities have informed the development of a syndemic framework aimed at ending HCV with strategies focused on disrupting transmission in real time while also addressing HIV and STIs.
-
No Missed Opportunities: A Client-Centered Telehealth Model for Hepatitis C in Inpatient Substance Use Treatment Programs
People who use drugs (PWUDs) face structural barriers to access prevention and care for hepatitis C (HCV) infection. While many inpatient substance use treatment programs (ISUTPs) often screen for HCV, few provide treatment, leading to missed opportunities for care. This presentation will introduce a client-centered telehealth model, initiating HCV treatment during detoxification and rehabilitation to enhance early engagement and ensure continuity of care.
-
Social Support Limitations and Hepatitis C Diagnosis Among High-Risk Adults in the U.S.: An Analysis of NHANES 2017–March 2020 Pre-Pandemic Data
Hepatitis C virus (HCV) remains a serious public health concern in the U.S., especially among high-risk groups. While social support is thought to influence health outcomes, its role in HCV diagnosis is less clear. Using pre-pandemic NHANES data (2017–March 2020), this study explored whether limitations in social support measured by self-reported access to routine care and inability to obtain needed medical care were associated with HCV screening outcomes among high-risk adults.
-
Participant Centered Recommendations for Contingency Management Program Implementation
Contingency Management (CM) is a behavioral intervention option for stimulant use that involves immediate, tangible rewards to individuals to reinforce positive self-identified behavior change. In 2023, in response to rising rates of stimulant overdose deaths, California became the first state in the U.S. to offer CM as a benefit through public insurance. Having already embraced CM over two decades prior through the Positive Reinforcement Opportunity Project (PROP)—originally designed for men who have sex with men to reduce sexually transmitted infections through reducing methamphetamine use—San Francisco was well positioned to expand this model, and over the last two years expanded CM to more than a dozen programs throughout the city benefitting diverse populations.
-
Blueprint for Expanding HIV Testing in Your Community
This presentation will highlight how to build a successful HIV testing program in the community. These are not abstract methods, but concrete steps to provide a clear plan on creating an HIV testing program that will ensure more people will have access to free, rapid testing.
-
Developing Linkage to Comprehensive Prevention Services in an Emergency Department Setting
This presentation will discuss the opportunities for implementing linkage to comprehensive services by assessing populations who are seen in the ED testing for STIs, including syphilis and HIV. We will explore the operations of identifying eligible patients, including our collaborations with the public health department, our Infectious Disease Clinic, and our Title V Clinic. We will highlight what is going well and discuss areas of improvement.
This presentation will also review the successes and challenges of launching a rapid PrEP program in an ED setting. -
Integration Pre-Exposure Prophylaxis in Emergency Medicine: A Single-Center Model at Tampa General Hospital
As part of the Hillsborough Health Equity Plan, a formative research initiative was conducted to increase the uptake of pre-exposure prophylaxis (PrEP) among Black and Latinx men who have sex with men (MSM) aged 25–34 in Hillsborough County, Florida. The study explored patient and provider experiences within on-demand care settings, such as urgent care clinics and emergency departments (EDs), where opportunities for PrEP intervention are often missed.
-
HCV (Testing, Linkage and Treatment) in the Time Before and After COVID in Alabama
In the US and globally, there have been two secular events exogenous to the HCV epidemic that has impacted HCV negatively. The first is well documented with the accompanying rise in the Opioid epidemic resulting in the uptick in HCV infections particularly among the population younger than the baby boomer generation. The second is the advent of COVID-19 that caused disruptions in testing, linkage and treatment of people living with Hepatitis C. We showcase the impact COVID 19 had on our testing program in Alabama.
-
Integrated Data Management Systems Accelerate HCV Elimination: Evidence from a US-based Patient Re-engagement Program
This study aims to assess the follow-up eligibility of individuals with HCV presumed LTFU. Pre-contact investigation (PCI) to assess ineligibility, including due to death or outdated contact information, was encouraged. Data came from the patient registries of 23 of 30 grant-funded organizations in different clinical, community and geographical settings. Data sources included patient, state, prison, and public records.
-
Treating Hepatitis C in Syringe Service Programs in Kentucky
The Target4 project partners with the University of Kentucky’s Bluegrass Care Clinic to integrate Hepatitis C telehealth services into syringe services programs throughout the commonwealth to address access barriers, improve treatment outcomes, and progress Hepatitis C elimination efforts in the Commonwealth. This presentation will discuss the process used to integrate telehealth services into the harm reduction environment in partnership with the local health departments, and share outcomes, successes, and lessons learned along the way.
-
Deconstructing Intersectional Trauma: Empowering Black LGBTQIA+ Men in Therapy and Behavioral Health Services
This presentation offers a clinical and social work-centered approach to addressing the mental health needs of Black LGBTQIA+ men through trauma-informed, culturally responsive, and identity-affirming strategies. This session will explore how toxic stress stemming from early-life adversity impacts emotional regulation, relationship-building, and self-worth. Special emphasis will be placed on how systemic oppression, societal stigma, and the lack of culturally competent mental health services heighten these challenges.
-
High Retention and Acceptability of Long-Acting Injectable PrEP among Underserved Urban Populations: Findings from a Community-Based Health Center in Newark, NJ.
The North Jersey Community Research Initiative (NJCRI) conducted a retrospective chart review to evaluate real-world utilization of oral and long-acting injectable PrEP (LA-Cabotegravir) among individuals accessing services between 2024 and 2025. NJCRI serves a predominantly Black and Brown, urban population in Newark, NJ, many of whom face housing instability, food insecurity, and limited access to affirming healthcare.
-
Learning Across Borders: What the U.S. Can Learn from LMIC Contraceptive Rollouts for Injectable PrEP Implementation
The U.S. has approved long-acting injectable PrEP options such as cabotegravir (Apretude) and lenacapavir (Yzugo), yet major challenges remain around equitable access, demand generation, and health-system readiness. This project explores what the United States can learn from low- and middle-income countries (LMICs) that successfully expanded injectable contraceptives, an intervention with striking parallels to injectable PrEP.
-
Linking Syphilis Surveillance to HIV Prevention: A Workflow Model to Promote PrEP Uptake in Marginalized Communities in Texas
Since 2018, Texas has faced a steep rise in syphilis cases particularly among marginalized groups such as Hispanic and non-Hispanic Black individuals. These findings are parallel to HIV trends in Texas. This model merges surveillance with proactive prevention and clinical coordination, targeting individuals at heightened HIV risk. Ongoing data collection on patient demographics, barriers, and facilitators will optimize implementation and elevate prevention outcomes in underserved communities.
-
Scaling PrEP in Women’s Health: Findings from a Pilot on OBGYN Practices in Mississippi
Strengthening OBGYN capacity to integrate PrEP into routine care is critical to reducing HIV incidence and advancing health equity for Black women in Mississippi. Findings will guide a forthcoming statewide, grant-funded initiative to scale PrEP delivery in women’s health settings, supporting the Ending the HIV Epidemic Initiative’s goals and addressing persistent disparities in HIV prevention access and outcomes.
-
Community at the Core: Building Trust and Linkage to HIV/STI Care Among Marginalized Populations in the Memphis TGA
This presentation explores replicable models of syndemic prevention in underserved Southern communities.
-
Impact of a Multidisciplinary Healthcare Program on Healthcare Engagement of Young Adults Living with HIV
Adolescents and young adults (AYA) living with human immunodeficiency virus (HIV) experience significant challenges with healthcare engagement. This population experiences lower rates of retention in care compared to their adult counterparts, resulting in poor adherence to antiretroviral therapy, higher viral load, and lower CD4 counts that negatively impact their health.
This study explored how involvement with a multidisciplinary healthcare team impacts healthcare engagement and identified facilitators and barriers to retention of care from the perspectives of AYA living with HIV.
-
Understanding the Sociocultural Context of HIV Outcomes for Transgender Women of Color Age 50+: A Secondary Analysis of the Transgender Women of Color Initiative Evaluation and Technical Assistance Center (TETAC) Dataset
Recent data from the U.S estimated that over half (57%) of transgender women (TW), aged 50+, are living with HIV. Findings lacked analysis by age, gender, and race/ethnicity, but found 62% HIV prevalence among Black trans women, suggesting potential HIV disparities for older TW of color. This study focused on HIV outcomes and health services access for TW aged 50 and older, making important contributions to the context of care for this population sub-group, who shoulder disproportionately high HIV prevalence. Findings highlight the critical role of support services in HIV care engagement and the potential for expanded access and intergenerational peer support programs to ameliorate HIV-related disparities based on age and race.
-
Using Community Health Workers to Overcome Obstacles to Care Engagement as a Southern CBO
In this session, participants will learn about the core elements of a community -based syndemic approach to HIV care engagement to enhance capacity to support PLWH throughout the HIV care continuum. This workshop will demonstrate how community health workers improve involvement in comprehensive prevention services.
-
Patient-Reported Outcomes in Clinical Trials Assessing the Effectiveness of Cabotegravir + Rilpivirine Long-Acting Injections as Antiretroviral Therapy: A Systematic Review
This systematic review explores the role of CAB + RPV-LA injectables in antiretroviral therapy (ART), with a focus on patient-reported outcomes from five key clinical trials.
-
Testing and Treatment Services for HIV, STIs, and Hepatitis C at Substance Use Treatment Facilities Serving Clients in the Ending the HIV Epidemic Priority Jurisdictions of the U.S.
This session presents data from the National Substance Use and Mental Health Services Survey (2023) conducted by the Substance Abuse and Mental Health Services Administration to present the current state of availability of testing and treatment services for HIV, HCV, and STIs.